Christine Mundkur

CIK 1237264 · Chief Executive Officer · last filed 2026-05-22

Christine Mundkur is a Chief Executive Officer who has filed 19 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for MNKD, was dated May 22, 2026. Across all open-market trades the lifetime net is +$75.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions. 6 SEC filings were submitted jointly with CARDINAL HEALTH INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$2.13M
Companies
3
Total Filings
19
Lifetime Open-Market Net
$75.0K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

MNKD price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers
CARDINAL HEALTH INC — 6 joint filings, latest 2025-11-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MNKD Director 27,675 $3.76 $104.1K $75.0K 10 2026-05-22
CAH Director 7,536 $269.35 $2.03M $0 5 2025-11-06
BARR PHARMACEUTICALS INC (BRL) Delisted Chief Executive Officer 3,096 — — $0 3 2008-11-19

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-22 MNKD Grant (A) — $0 EDGAR
2025-11-06 CAH Grant (A) +1,067 $0 EDGAR
2025-05-16 MNKD Grant (A) — $0 EDGAR
2024-11-07 CAH Grant (A) +1,730 $0 EDGAR
2024-05-17 MNKD Grant (A) — $0 EDGAR
2023-11-16 CAH Grant (A) +1,965 $0 EDGAR
2023-05-26 MNKD Grant (A) — $0 EDGAR
2022-11-10 CAH Grant (A) +2,308 $0 EDGAR
2022-09-19 CAH Grant (A) +466 $0 EDGAR
2022-05-12 MNKD Grant (A) — $0 EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.